Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer.

Am J Hematol · 2018 · PMC5947542 · PMID 29396864

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significanceP = .07so close (0.05 < p ≤ 0.1)

8 The CATCH study reported a 35% decreased risk of VTE in patients receiving tinzaparin when compared to warfarin over a 6‐month study period, but the result did not reach statistical significance ( P = .07). 9 With respect to bleeding risk, the rates of major bleeding in the LMWH and warfarin arms of CLOT and CATCH were similar to the findings reported in the current study.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.